Geneos Wealth Management’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-675
Closed -$14K – 2722
2022
Q2
$14K Hold
675
– – ﹤0.01% 1847
2022
Q1
$15K Buy
+675
New +$12.5K ﹤0.01% 1927
2021
Q4
– Sell
-3,125
Closed -$55K – 2913
2021
Q3
$55K Hold
3,125
– – ﹤0.01% 1446
2021
Q2
$63K Sell
3,125
-520
-14% -$10.7K ﹤0.01% 1376
2021
Q1
$72K Hold
3,645
– – ﹤0.01% 1443
2020
Q4
$60K Buy
3,645
+895
+33% +$13.8K ﹤0.01% 1372
2020
Q3
$34K Buy
2,750
+1,900
+224% +$26K ﹤0.01% 1420
2020
Q2
$9K Hold
850
– – ﹤0.01% 1964
2020
Q1
$9K Hold
850
– – ﹤0.01% 1874
2019
Q4
$14K Hold
850
– – ﹤0.01% 1857
2019
Q3
$11K Sell
850
-1,000
-54% -$14.2K ﹤0.01% 1876
2019
Q2
$27K Sell
1,850
-450
-20% -$6.9K ﹤0.01% 1496
2019
Q1
$38K Hold
2,300
– – ﹤0.01% 1282
2018
Q4
$37K Sell
2,300
-200
-8% -$3.59K ﹤0.01% 1241
2018
Q3
$42K Sell
2,500
-50
-2% -$800 ﹤0.01% 1259
2018
Q2
$39K Sell
2,550
-7,150
-74% -$124K ﹤0.01% 1167
2018
Q1
$164K Sell
9,700
-2,975
-23% -$48K 0.01% 591
2017
Q4
$179K Sell
12,675
-750
-6% -$11.4K 0.02% 571
2017
Q3
$225K Sell
13,425
-13,825
-51% -$212K 0.02% 482
2017
Q2
$414K Buy
27,250
+5,425
+25% +$77.1K 0.04% 329
2017
Q1
$275K Sell
21,825
-2,000
-8% -$23.9K 0.03% 400
2016
Q4
$283K Buy
23,825
+5,114
+27% +$66.3K 0.04% 378
2016
Q3
$275K Sell
18,711
-3,614
-16% -$55.5K 0.04% 376
2016
Q2
$366K Buy
22,325
+2,050
+10% +$33.1K 0.05% 309
2016
Q1
$358K Buy
+20,275
New +$330K 0.05% 301

Other funds holding MNDT

Geneos Wealth Management's MNDT Position: Q3 2022 in Review

Geneos Wealth Management sold out of Mandiant, Inc. Common Stock (MNDT) in Q3 2022, closing a stake of 675 shares — an estimated $14K sold.

Geneos Wealth Management first reported a position in MNDT in Q1 2016 and held it in 25 quarters. The position peaked at $414K in Q2 2017. 3 funds tracked by Wall St. Rank hold MNDT as of Q3 2022.

  • Geneos Wealth Management reported no remaining Mandiant, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 675 Mandiant, Inc. Common Stock shares in Q3 2022, an estimated $14K.
  • Geneos Wealth Management first reported a position in Mandiant, Inc. Common Stock in Q1 2016 and held it in 25 quarters.
  • Geneos Wealth Management's Mandiant, Inc. Common Stock position peaked at $414K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.